CA
NZ
UK
AU
IND
US
A Form 4 filed with the SEC on September 8, 2026 discloses that Shahar Tamari, Chief Operating Officer and Director of Global-E Online Ltd. (NASDAQ:GLBE), disposed of 24,999 ordinary shares on September 3, 2026, pursuant to a Rule 10b5-1 trading plan.
Richard S. Kraemer, Senior Executive Vice President and Chief Financial Officer of Fulton Financial Corp, filed a Form 4 on September 8, 2026, disclosing multiple changes in beneficial ownership of common stock and restricted stock units dated as early as June 6, 2026.
A Form 4 filed on September 8, 2026, disclosed that Sean Desmond, CEO and President of nCino, Inc. (NASDAQ:NCNO), exercised stock options and sold common stock on September 3, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
A Form 4 filed on September 8, 2026, with the U.S. Securities and Exchange Commission reports that John A. Carroll, VP and Chief Accounting Officer of Waste Management Inc (NYSE:WM), disposed of 1,365 shares of common stock on September 4, 2026.
Mark Dorfman, Executive Vice President, General Counsel, and Secretary of Leonardo DRS, Inc. (NASDAQ:DRS), filed a Form 4 on September 8, 2026, reporting the sale of 7,471 shares of common stock on September 4, 2026.
A Form 4 filed with the SEC on September 8, 2026, reported that Gordon Hunter, a director of Littelfuse Inc /DE (NASDAQ:LFUS), acquired a total of 8 shares of common stock on September 3, 2026, through two separate dividend-related transactions.
Kristina A. Cerniglia, a director at Littelfuse Inc /DE (NASDAQ:LFUS), filed a statement of changes in beneficial ownership on September 8, 2026, disclosing a common stock acquisition dated September 3, 2026.
Sohail Prasad, President and CEO of Destiny Tech100 Inc., filed a Form 4 on September 8, 2026, disclosing three open-market purchases of common stock totaling 56,000 shares between September 1 and September 3, 2026.
Director Birger Johannes Meyer-Gloeckner filed a Form 4 with the SEC on September 8, 2026, disclosing a net stock option exercise and same-day sale of ordinary shares in ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) on September 4, 2026.
Theodore Alan Huizenga, SVP and Chief Accounting Officer of Ultragenyx Pharmaceutical Inc., filed a Form 4 on September 8, 2026, disclosing a sale of common stock on September 3, 2026, related to RSU vesting.
Please wait processing your request...